ICWEA Statement on Gilead Sciences’ Licensing of Lenacapavir: A Step Toward Expanding HIV Prevention Choices
The International Community of Women Living with HIV Eastern Africa (ICWEA) welcomes Gilead Sciences' decision to license the production and sale of the generic version of Lenacapavir to six pharmaceutical…